Transcatheter tricuspid-valve repair significantly improves outcomes in patients with severe tricuspid regurgitation, with a win ratio of 2.42 favoring repair at 1 year.
Cardiac Valve Diseases and Treatments
Moving in medRxiv, bioRxiv, New England Journal of Medicine and Circulation.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 8
Add Cardiac Valve Diseases and Treatments as an interest in JClubFree on iPhone and Android · interests shape Home, Discover and your digest
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Cardiac Valve Diseases and Treatments
Newest first · last 60 days
Timely diagnosis and treatment of aortic stenosis improved modestly from 2023 to 2024 but remain suboptimal, with only 54-61% diagnosed within 30 days at a national level.
Performing TAVI before PCI is noninferior to PCI before TAVI regarding 1-year outcomes in patients with severe aortic stenosis and coronary artery disease, with a 22.2% versus 24.2% event rate.
Add Cardiac Valve Diseases and Treatments as an interest in JClub
Browse JClub
Journals this month
- bioRxiv6157
- medRxiv1716
- PNAS447
- Sci Adv354
- JAMA262
- Environ Res230
- BMJ182
- Environ Pollution165
- Nat Commun161
- Science141
- Nature138
- Lancet128
- Cell Rep120
- NEJM119
- mBio107
- Plant Cell Environ107
- Curr Biol106
- J Exp Bot106
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3